Skip to content
naulon
Not checkedNot checked for notices yet.

Transcatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model

Jose L. Navia, MD, Samir Kapadia, MD, Haytham Elgharably, MD and 7 more

JACC: Basic to Translational Science · 2018

doi:10.1016/j.jacbts.2017.08.003 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Patients with isolated functional or recurrent tricuspid regurgitation are often denied surgery because they are considered to be at high risk. Transcatheter valve therapy provides a less invasive alternative for tricuspid regurgitation associated with right heart failure. We have evaluated the feasibility of transcatheter tricuspid valve implantation of the NaviGate valved stent in a long-term swine model. The valved stent was successfully implanted through transjugular and transatrial approaches on the beating heart with excellent hemodynamic and valve performance. No conduction disturbance or coronary obstruction was observed. This technology could provide an alternative treatment for patients who are at high surgical risk with severe tricuspid regurgitation and compromised right ventricular function.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.